Prototype Tool Leverages AI to Predict Which COVID-19 Patients Most Likely to Develop Severe Symptoms

The tool indicated that a combination of small changes in levels of the liver enzyme alanine aminotransferase (ALT), patient-reported myalgia (aching muscles), and raised hemoglobin levels, most accurately predicted the development severe disease.
Internet network

Prototype Tool Leverages AI to Predict Which COVID-19 Patients Most Likely to Develop Severe Symptoms

The tool indicated that a combination of small changes in levels of the liver enzyme alanine aminotransferase (ALT), patient-reported myalgia (aching muscles), and raised hemoglobin levels, most accurately predicted the development severe disease.
DNA and virus

Cancer Gets a Global Genomic Map

The Pan-Cancer Analysis of Whole Genomes incorporated 2,658 whole genomes, 38 tumor types, 1,188 transcriptomes, and 1,300 scientists from 37 countries.
Data Medicine

Clinical Combinations

Clinicians pursue combining genotypes with phenotypes to provide more precise healthcare.
Timothy Chan

The Accelerating Race for Immunotherapy Biomarkers

As the market for immunotherapies grows, doctors’ interest in diagnostics to guide more precise treatment increases.
Robert Green

Of Known Significance

An exclusive Clinical OMICs conversation with the director of Genomes2People, Robert Green, M.D., MPH.
Jiyun Byun

Comprehesive Approach

Epic Sciences has retooled its management team and combined CTC and ctDNA technologies in its pursuit of comprehensive cancer profiling.
coronavirus,3d render

COVID-19 Patients May Carry Virus after Symptoms Have Resolved

The study found that the incubation period of the virus was five days for all but one of the patients, and the average duration of symptoms was eight days. However, the length of time that patients remained contagious after resolution of their symptoms ranged from one to eight days.
Doctor holding oxygen ambu bag over patient given oxygen to patient by intubation tube in ICU/Emergency room

ACE inhibitors and Angiotensin Receptor Blockers May Increase Mortality Rate In Elderly COVID-19 Patients

These highly prescribed medications change cell surface protein expression, which is particularly problematic in cells in the respiratory system—tissue that is vulnerable to targeting and attack by the COVID-19 virus.
Coronavirus Covid-19 Vaccine

Moderna Charts Fast Track of SARS-CoV-2 Vaccine to Clinical Trials

As Moderna's vaccine development moves at unprecedented speed, the company's CEO explains how they have moved so quickly and why he is hopeful that their pace will continue.
I better not be getting sick

Stanford Researchers Dig Into Community Spread of COVID-19

The researchers explain why it is an urgent matter for environmental engineers and scientists to collaborate on pinpointing viral and environmental characteristics that affect COVID-19 transmission via surfaces, the air, and fecal matter.

Abbott Launching ID NOW COVID-19 Tests, Offering Positive Results in Five Minutes

Company expects to deliver 50,000 tests per day of the rapid, instrument-based, isothermal system designed for qualitative detection of infectious diseases.
Internet network

Prototype Tool Leverages AI to Predict Which COVID-19 Patients Most Likely to Develop Severe Symptoms

The tool indicated that a combination of small changes in levels of the liver enzyme alanine aminotransferase (ALT), patient-reported myalgia (aching muscles), and raised hemoglobin levels, most accurately predicted the development severe disease.
Myanmar: Rhesus Macaque

New Study Suggests COVID-19 Reinfection Unlikely

The study used four adult Chinese rhesus macaques and found that those monkeys that had been re-exposed to SARS-CoV-2, like the unexposed control monkey, showed no recurrence of COVID-19.

COVID-19 Symptom Checker for Individual Monitoring

COVID-19 Compass is based on CDC guidelines, best clinical practices, illness severity, and risk factors such as age, gender, location, potential exposure and pre-existing health conditions.

Largest Study to Date of COVID-19 Susceptibility Launched

Researchers will launch the study involving 1,000 subjects—consisting of COVID-19 patients and their partners and first-degree relatives as controls—to compare a variety of genomic and other biological variables between those patients who show no or mild symptoms and those who show severe illness.

New Institute to Seek AI-Based Solutions to Curbing COVID-19 Pandemic

C3.ai DTI will focus its research on AI, machine learning, the internet of things, big data analytics, human factors, organizational behavior, ethics, and public policy.

Clinical Research in a Real-Time Sequencing Age

Oxford Nanopore’s DNA/RNA sequencing technology delivers ultra-long reads (up to 2 Mb), enabling rapid and comprehensive analysis of variants. With devices scalable from portable to benchtop, nanopore sequencing offers a cost-effective solution to the challenges faced by traditional sequencing platforms.

From Bench to Clinic—The Potential of New Sequencing Tools

Sponsored content brought to you by As genome sequencing technology advances, researchers are increasingly exploring emerging tools for a host of potential clinical applications. Andrew...

Mainstreaming Precision Oncology

Sponsored content brought to you by   What if every patient’s oncologist or lab testing personnel had access to an online digital encyclopedia of cancer mutations,...
Scroll Up